NX210c Demonstrates Therapeutic Potential to Restore Blood–Brain Barrier in a QSP Model of Relapsing–Remitting Multiple Sclerosis

International Journal of Molecular Sciences Giulia Russo 1,2 , Fianne Sips 3 , Simona Catozzi 4 , Pauline Bambury 4 , Annette Janus 5 , Mario Torchia 4 , Valentina Di Salvatore 1 , Luca Emili 4 , Daniel Röshammar 4,* , Francesco Pappalardo 1,2 and Yann Godfrin 5 Department of Drug and Health Sciences, Università degli Studi di Catania, 95125 Catania, Italy; [email protected] (G.R.); [email protected] (V.D.S.); [email protected] (F.P.) Mimesis Srl, 95125 Catania, Italy InSilicoTrials Technologies B.V., 5232 AC ‘s-Hertogenbosch, The Netherlands; [email protected] InSilicoTrials Technologies Spa, 34123 Trieste, Italy; [email protected] (S.C.);[email protected] (P.B.); [email protected] (M.T.); [email protected] (L.E.) Axoltis Pharma, 69008 Lyon, France; [email protected] (A.J.); [email protected] (Y.G.) * Correspondence: [email protected] PDF Version

The release as fetched from its publisher. axoltis.com ↗